Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacologic management of cognitive impairment induced by cancer therapy
Philipp Karschnia, Michael W. Parsons, Jörg Dietrich
The Lancet Oncology (2019) Vol. 20, Iss. 2, pp. e92-e102
Closed Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors
Marie Lange, Florence Joly, Janette Vardy, et al.
Annals of Oncology (2019) Vol. 30, Iss. 12, pp. 1925-1940
Open Access | Times Cited: 484
Management of common clinical problems experienced by survivors of cancer
Jon Emery, Phyllis Butow, Julia Lai‐Kwon, et al.
The Lancet (2022) Vol. 399, Iss. 10334, pp. 1537-1550
Closed Access | Times Cited: 153
Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions
Ayal A. Aizer, Nayan Lamba, Manmeet S. Ahluwalia, et al.
Neuro-Oncology (2022) Vol. 24, Iss. 10, pp. 1613-1646
Open Access | Times Cited: 92
Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management
Ben Fleming, Paul Edison, Laura Kenny
BMJ (2023), pp. e071726-e071726
Closed Access | Times Cited: 42
The effect of non-pharmacological interventions on cognitive function in cancer: an overview of systematic reviews
Darren Haywood, Ashley M. Henneghan, Alexandre Chan, et al.
Supportive Care in Cancer (2025) Vol. 33, Iss. 2
Open Access | Times Cited: 3
Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group
Samantha Mayo, Maryam B. Lustberg, Haryana M. Dhillon, et al.
Supportive Care in Cancer (2020) Vol. 29, Iss. 6, pp. 2821-2840
Closed Access | Times Cited: 108
Long-Term Cognitive Dysfunction in Cancer Survivors
Zuzana Országhová, Michal Mego, Michal Chovanec
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 102
Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”), a condition that significantly impairs the quality of life of many cancer survivors
Xiaojia Ren, Diana Boriero, Luksana Chaiswing, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2019) Vol. 1865, Iss. 6, pp. 1088-1097
Open Access | Times Cited: 99
Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?
Martin C. Tom, Daniel P. Cahill, Jan C. Buckner, et al.
American Society of Clinical Oncology Educational Book (2019), Iss. 39, pp. 133-145
Closed Access | Times Cited: 82
Strategies to Prevent or Remediate Cancer and Treatment-Related Aging
Jennifer Guida, Tanya Agurs‐Collins, Tim A. Ahles, et al.
JNCI Journal of the National Cancer Institute (2020) Vol. 113, Iss. 2, pp. 112-122
Open Access | Times Cited: 76
Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach?
Sanne B. Schagen, Andrey S. Tsvetkov, Annette Compter, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 3, pp. 173-185
Closed Access | Times Cited: 65
BDNF Augmentation Using Riluzole Reverses Doxorubicin-Induced Decline in Cognitive Function and Neurogenesis
Manal T. Usmani, Robert P. Krattli, Sanad M. El-Khatib, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 3, pp. 838-852
Open Access | Times Cited: 22
Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy
Noemí Cerulla, J. Blas Navarro, Núria de la Osa
Journal of Cancer Survivorship (2020) Vol. 14, Iss. 4, pp. 464-482
Closed Access | Times Cited: 54
Pathogenesis, Assessments, and Management of Chemotherapy-Related Cognitive Impairment (CRCI): An Updated Literature Review
Longqin Lv, Shanping Mao, Huimin Dong, et al.
Journal of Oncology (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 54
Nonpharmacological interventions for cancer-related cognitive impairment in adult cancer patients: A network meta-analysis
Yingchun Zeng, Juntao Dong, Meiling Huang, et al.
International Journal of Nursing Studies (2020) Vol. 104, pp. 103514-103514
Closed Access | Times Cited: 53
Chemotherapy-Induced Cognitive Impairment and Hippocampal Neurogenesis: A Review of Physiological Mechanisms and Interventions
Melanie J. Sekeres, Meenakshie Bradley-Garcia, Alonso Martínez-Canabal, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12697-12697
Open Access | Times Cited: 50
Comorbidity of osteoporosis and Alzheimer’s disease: Is `AKT `-ing on cellular glucose uptake the missing link?
Karin Fehsel, Julia Christl
Ageing Research Reviews (2022) Vol. 76, pp. 101592-101592
Closed Access | Times Cited: 29
Randomized Controlled Trial of Virtually Delivered Cognitive Behavioral Therapy for Insomnia to Address Perceived Cancer-Related Cognitive Impairment in Cancer Survivors
Sheila N. Garland, Joshua Tulk, Josée Savard, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 17, pp. 2094-2104
Closed Access | Times Cited: 6
Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions
Giovana R. Onzi, Nathalia D’Agustini, Solange Cristina García, et al.
Drug Safety (2022) Vol. 45, Iss. 6, pp. 601-621
Closed Access | Times Cited: 23
Efficacy of acupuncture in treating chemotherapy-related cognitive impairment in breast cancer patients: A systematic review and meta-analysis protocol
Lishi Liu, Zihan Meng, Jun Yan
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0318984-e0318984
Open Access
Cognitive remediation in breast cancer survivors: A study protocol
P Nunez, Véronique Gerat-Muller, C. Bellera, et al.
Contemporary Clinical Trials (2025) Vol. 152, pp. 107858-107858
Open Access
Natural trajectory subclasses of cognitive impairment in breast cancer patients experiencing insomnia
Oxana Palesh, Sarah Braun, Tina Truong, et al.
Cancer (2025) Vol. 131, Iss. 8
Open Access
Treatment and disease‐related complications in multiple myeloma: Implications for survivorship
Rajshekhar Chakraborty, Navneet S. Majhail
American Journal of Hematology (2020) Vol. 95, Iss. 6, pp. 672-690
Open Access | Times Cited: 37
Protective effects of camellia and olive oils against cognitive impairment via gut microbiota-brain communication in rats
Sheng-Yi Chen, Ming-Hung Weng, Zih‐Ying Li, et al.
Food & Function (2022) Vol. 13, Iss. 13, pp. 7168-7180
Closed Access | Times Cited: 20
Advances in Therapeutic Research on Chemotherapy-Related Cognitive Impairment
立石 刘
World Journal of Cancer Research (2025) Vol. 15, Iss. 01, pp. 9-15
Closed Access
Page 1 - Next Page

Scroll to top